Skip to main content
Novartis Home

Language & Country Selector for Desktop

language-selector-globe Global | en

Choose Location

  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Global

Choose Location

International Americas Asia Pacific Europe Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About 
      • Board of Directors 
        • Joerg Reinhardt 
        • Simon Moroney 
        • Nancy Andrews 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Andreas von Planta 
        • Charles Sawyers 
        • William Winters 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Klaus Moosmayer 
        • Marie-France Tschudin 
        • Lutz Hegemann 
        • Kees Roks 
        • Richard Saynor 
        • Michael Willi 
      • Strategy 
        • People and Culture 
        • Data and Digital 
      • Products 
      • Innovative Medicines 
      • Sandoz 
      • Diversity, Equity & Inclusion 
        • Equity 
        • Diversity, Equity & Inclusion Governance and Community 
        • Inclusivity 
        • Parental Leave 
        • Society 
      • Manufacturing 
      • Quality 
        • Audit program 
        • Novartis Quality Management System (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Awards and Recognition 
      Male scientist in lab About Novartis
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient Organization Funding 
      • COVID-19: Patients and Caregivers 
      • Stories: Patients Perspectives 
      Couple holding hands Patients & Caregivers
    • Healthcare Professionals 
      • Medical Congresses and Events 
        • Abstract summaries for EULAR 
        • Abstract summaries for ACR 
        • Abstract summaries for EADV 
      • Products 
      • Novartis Pipeline 
      • Managed Access Programs 
        • Novartis Gene Therapies Managed Access Program 
      • Novartis External Funding 
      • Healthcare Professional Resources by Country 
      • Investigator-Initiated Trials / Studies 
      • Transparency and Disclosure 
      • Novartis Medical Information 
        • Submit medical enquiry 
      Doctor Healthcare Professionals
    • Research & Development 
      • Novartis Institutes for BioMedical Research 
        • Collaborations 
        • NIBR Global Scholars Program 
      • Technology Platforms 
        • Radioligand Therapy 
        • Gene Therapy 
        • Cell Therapy 
      • Research Disease Areas 
        • Immuno-oncology research at Novartis 
        • Oncology research at Novartis 
        • Cardiovascular and metabolic disease research at Novartis 
        • Autoimmunity, transplantation and inflammatory disease research at Novartis 
        • Ophthalmology research at Novartis 
        • Neuroscience Research at Novartis 
        • Musculoskeletal Disease Research at Novartis 
        • DAx: exploratory disease research at Novartis 
      • Research Locations 
        • Novartis Institute for Tropical Diseases 
      • Novartis Pipeline 
      • Translational Medicine 
      • Research & Development Approach 
      • Research Collaborations 
      • Open Source Science 
      • Stories from our Labs 
      Scientists conducting innovative research experiments Research & Development
    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-Based Pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis Access Principles 
        • Novartis Oncology Access 
        • Patents and Licensing 
      • Ethics, Risk and Compliance 
        • Ethical Behavior 
        • Compliance 
        • Human Rights 
        • Learning and Engagement 
        • Risk management 
      • Environmental Sustainability 
        • Climate 
        • Waste 
        • Water 
      • Global Health 
        • Anti-Microbial Resistance (AMR) 
        • Avoidable Blindness 
        • Chagas Disease 
        • Leprosy 
        • Malaria 
        • Sickle Cell Disease (SCD) 
        • Novartis Foundation 
      • Diversity & Inclusion 
      • Reporting 
        • ESG Rating Performance 
        • Codes, Policies and Guidelines 
        • Materiality Assessment 
        • Transparency and Disclosure 
        • Targets 
        • Positions 
      • ESG Index 
      Young patients waiting outside an hospital in Rwanda Environmental, Social and Governance
    • Investors 
      • Event Calendar 
      • Financial Data 
        • Novartis Annual Results 
        • Novartis Quarterly Results 
        • Novartis SEC Filings 
        • Product Sales 
        • Fixed-Income Securities 
        • Expected Currency Impact 
      • Share Data & Analysis 
        • Share Monitor 
        • Dividend Information 
        • Share Ownership 
        • Share Overview 
        • Return On Investment Calculator 
      • Shareholder Information 
        • General Meetings 
        • American Depository Receipts (ADR) 
        • Share Buy-Back 
        • Frequently Asked Questions 
      • Company Overview 
        • Corporate Governance 
      • Novartis Annual Reporting Suite 
        • Reporting Archive 
        • Publications Order Form 
      • ESG 
      Hands marking a test tube Investors
    • News 
      • News Archive  
      • Media Library  
      • Stories 
      • Subscribe 
      People at the table with screens News
    • Careers 
      • Career Search 
      • Our Teams 
        • Careers in Commercial 
        • Careers in Communications and Engagement 
        • Careers in Consulting 
        • Careers in Digital 
        • Careers in Health, Safety & Environment 
        • Careers in Information Technology (IT) 
        • Careers in Medical & Development 
        • Careers in People & Organization 
        • Careers in Procurement 
        • Careers in Research 
        • Careers in Strategy 
        • Careers in Manufacturing and Supply 
        • Ethics, Risk & Compliance (ERC) 
        • Careers in Legal 
      • Career Programs 
        • Community Exploration & Learning Lab (CELL) 
        • Postdoc Program 
      • Early Talent 
        • US NIBR Internship Programs 
      • International Careers 
      • Personal Growth 
      • Well-being 
      A female Novartis researcher Careers
    • Clinical Trials 
      doctor taking the blood pressure of her patient Clinical Trials
    • Partnering 
      Business people working in a dark room Partnering
    • Supplier Portal 
    • Report side effects 
    • Contacts 
      Office Cubicle Contacts
    Visitors enjoying the visit of the Novartis Pavillon Home
  1. Home
  2. Careers
  3. Career Search
  4. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date
Job Title Site Location Division Business Functional Area Date
Associate MR, Chugoku/Shikoku Area 全国 Japan SANDOZ Commercial OPS SIR SZ Sales Jan 27, 2023
Senior Lead, CX Content Creation Tokyo Japan PHARMA Japan Marketing Jan 27, 2023
Senior Lead, CX (Customer experience) Strategy Tokyo Japan PHARMA Japan Marketing Jan 27, 2023
Lead, Medical excellence 東京 Japan PHARMA Japan Jan 27, 2023
Lead,CX Strategy Tokyo Japan PHARMA Japan Marketing Jan 26, 2023
Head Legal GDD Japan Tokyo Japan PHARMA Japan Legal & Intellectual Property & Compl. Jan 26, 2023
Lead, General Medicines Medical​ Tokyo Japan PHARMA Japan Research & Development Jan 25, 2023
Associate/Lead, Medical Science (MSE) Tokyo Japan PHARMA Japan Research & Development Jan 25, 2023
Japan Program Head Tokyo Japan Global Drug Development IHD DU GDD Research & Development Jan 24, 2023
Japan Program Clinical Head Tokyo Japan Global Drug Development CD&A GDD Research & Development Jan 24, 2023
P&O Services - Payroll and Time Specialist Tokyo Japan SANDOZ Commercial OPS SIR SZ Human Resources Jan 23, 2023
Senior lead, Solid Tumor Medical Tokyo Japan PHARMA Japan Research & Development Jan 23, 2023
Associate / Lead, Medical Information Tokyo Japan PHARMA Japan Research & Development Jan 23, 2023
Associate / Lead, RWE Tokyo Japan PHARMA Japan Research & Development Jan 23, 2023
Head of RWE and Evidence Excellence Tokyo Japan PHARMA Japan Research & Development Jan 23, 2023
P&O Services – H2R Specialist Tokyo Japan SANDOZ Commercial OPS SIR SZ Human Resources Jan 22, 2023
Total Rewards (Associate to Senior Manager) Tokyo Japan CTS HR NBS Human Resources Jan 20, 2023
ER Investigation Associate / Manager Tokyo Japan PHARMA Japan Human Resources Jan 20, 2023
20946710 Associate MR Kyushu 九州 Japan SANDOZ Commercial OPS SIR SZ Sales Jan 19, 2023
Finance Control & Compliance (FC&C) Lead_#7 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Procure to Pay/Travel &Expense, Manager_#8 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
General Accounting(R2R), Manager_#10 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Order to Cash/Treasury Cash Management, Manager_#9 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Senior Manager, Country Tax_#1 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Order to Cash/Treasury Cash Management, Lead_#5 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Procure to Pay/Travel &Expense, Lead_#6 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Jan 19, 2023
Sales Execution Manager, Oncology Bio BU 東京 Japan SANDOZ Commercial OPS SIR SZ Sales Jan 19, 2023
Head of warehouse & distribution Dept Tokyo Japan Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Jan 19, 2023
Senior Regulatory Writer Tokyo Japan Global Drug Development GDO GDD Research & Development Jan 19, 2023
Organization Development Leader Tokyo Japan PHARMA Japan Human Resources Jan 19, 2023
Senior Lead, Omnichannel Capability Tokyo Japan PHARMA Japan Marketing Jan 18, 2023
Associate, Communications Tokyo Japan SANDOZ Commercial OPS SIR SZ Communications & Public Affairs Jan 17, 2023
Innovative Medicines Japan Business Partner Tokyo Japan PHARMA Japan Human Resources Jan 16, 2023
Manager, Life Cycle Management, PfM Group Tokyo Japan SANDOZ Commercial OPS SIR SZ BD&L & Strategic Planning Jan 11, 2023
Group Manager, Portfolio Management Group 東京 Japan SANDOZ Commercial OPS SIR SZ Jan 11, 2023
Lead,New Product Planning & Launch Excellence (NPP&LEX) Group Tokyo Japan PHARMA Japan Marketing Jan 10, 2023
General Accounting(R2R), Lead_#3 Tokyo Japan SANDOZ Commercial OPS SIR SZ Audit & Finance Dec 27, 2022
MR_関東/東北エリア 全国 Japan SANDOZ Commercial OPS SIR SZ Sales Dec 23, 2022
Lead, Omnichannel Capability Tokyo Japan PHARMA Japan Sales Dec 23, 2022
MSL_Oncology(Hematology/Solid Tumor) Tokyo Japan ONCOLOGY ONCOLOGY BU Research & Development Dec 21, 2022
MSL(Lipid,NS) Tokyo Japan ONCOLOGY ONCOLOGY BU Research & Development Dec 21, 2022
MSL Tokyo Japan ONCOLOGY ONCOLOGY BU Research & Development Dec 21, 2022
Lead, RWE Tokyo Japan PHARMA Japan IMI Research & Development Dec 16, 2022
Lead / Senior Lead, Public Affairs 東京 Japan PHARMA Japan Dec 15, 2022
Data Scientist / Business Analyst Tokyo Japan PHARMA Japan Marketing Dec 15, 2022
Capability Transformation Lead Tokyo Japan PHARMA Japan Sales Dec 14, 2022
Supply Operation Manager Tokyo Japan Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Dec 13, 2022
Customer solution Lead/Associate Tokyo Japan PHARMA Japan Marketing Dec 08, 2022
Senior RLT Healthcare System Tokyo Japan ONCOLOGY ONCOLOGY BU Market Access Dec 05, 2022
Group Manager, QC (Head of QC) Sasayama Japan Novartis Technical Operations QUALITY Quality Nov 10, 2022

Pagination

  • Page 1
  • Next page ››

Novartis

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • COVID-19 Info Center
  • ESG
Explore
  • Stories
  • Diseases
  • Locations
  • Products
  • Novartis Pipeline
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Gyroscope Therapeutics
Footer Bottom
© 2023 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience